Kang YK, Kim HD, Yook JH, Park YK, et al. Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY. J Clin Oncol 2024 Jul 12:JCO2302167. doi: 10.1200/JCO.23.02167.
PMID: 38996201